Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.

Perugino C. et al, (2023), Rheumatology and therapy

Autoimmune pancreatitis in patients with inflammatory bowel disease - a real-world multicentre collaborative ECCO CONFER study.

Eder P. et al, (2023), Journal of Crohn's & colitis

IgG4-related disease

Nwaduru C. and Culver EL., (2023), Medicine (United Kingdom), 51, 405 - 411

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.

Abbas N. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 21, 1561 - 1570.e13

Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.

Liao W. et al, (2023), EClinicalMedicine, 59

Development of an algorithm for IgG4-related disease management.

Orozco-Gálvez O. et al, (2023), Autoimmunity reviews, 22

Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imaging.

Möller K. et al, (2023), Endoscopic ultrasound, 12, 181 - 199

Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study.

Schregel I. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma.

Lloyd C. et al, (2023), Digestive diseases and sciences, 68, 87 - 97

LiverMultiScan as an alternative to liver biopsy to monitor autoimmune hepatitis in the National Health Service in England: an economic evaluation.

Bajre M. et al, (2022), BMJ open, 12

A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis

Radford‐Smith DE. et al, (2022), Liver International, 42, 1344 - 1354

Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.

Iaccarino L. et al, (2022), Clinical and experimental rheumatology, 40 Suppl 134, 71 - 80

Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study.

Ramirez GA. et al, (2022), Rheumatology (Oxford, England), 61, e109 - e111

A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.

Selvaraj EA. et al, (2022), Hepatology communications, 6, 795 - 808

Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis.

Heneghan MA. et al, (2022), EClinicalMedicine, 46

Emerging therapy options for IgG4-related disease.

Lanzillotta M. et al, (2021), Expert review of clinical immunology, 17, 471 - 483

REAL WORLD EXPERIENCE OF THE NEW ACR-EULAR CLASSIFICATION CRITERIA FOR IGG4-RELATED DISEASE

Peters R. et al, (2021), GUT, 70, A174 - A175

The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases.

Cargill T. and Culver EL., (2021), Frontiers in immunology, 12

Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'.

Peters RJR. et al, (2020), Annals of the rheumatic diseases

Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.

Culver EL. et al, (2020), Liver international : official journal of the International Association for the Study of the Liver, 40, 2744 - 2757

Load More

1
2
3
4
5

Include forthcoming?